Overview

Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
Phase:
N/A
Details
Lead Sponsor:
University of Washington
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Dextrans
Pharmaceutical Solutions